Home » Clinical Trials »  Search Clinical Trials

Therapeutic Areas:  |  Dermatology

Search Medical Condition
Please enter condition
Please choose location from dropdown
Clear Trial Filters

Alopecia Clinical Trials

A listing of Alopecia medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

RESULTS

Found (7) clinical trials

Alopecia Areata is an autoimmune disease that commonly results in unpredictable, patchy hair loss that can affect the scalp and body. Alopecia can have major impacts on the quality of life of those diagnosed. If you or a loved one suffer from hair loss caused by Alopecia, a research study ...

Phase

Seeking adults with severe to very severe alopecia areata. Alopecia areata is an autoimmune disease that commonly results in unpredictable, patchy hair loss that can affect the scalp and body. Alopecia can have major impacts on the quality of life of those diagnosed. If you or a loved one suffer ...

Phase

Clinical research study in alopecia areata (AA). The Allegro 2b/3 research study aims to find out if an investigational medication can help treat people with AA who have lost 50% or more of the hair on their head.  

Phase

Efficacy and Safety of LH-8 in Paediatric Alopecia Areata

Methods / trial design: Randomised, double-blind, vehicle-controlled multicentre trial in parallel groups. At screening (Visit 0), subjects will discontinue their previous treatment for alopecia areata, if any. Screening period will last up to 28 days. The 24-week treatment phase will include assessment Visits 1 to 3, which will take place ...

Phase

A Study Evaluating the Efficacy and Safety of SM04554 Topical Solution in Male Subjects With Androgenetic Alopecia

This multi-center, randomized, double-blind, placebo-controlled study, conducted in Turkey, will assess the efficacy and safety of topical SM04554 solution (0.15% and 0.25%) applied daily to the scalp of male androgenetic alopecia (AGA) subjects.

Phase

A Study of Baricitinib (LY3009104) in Participants With Severe or Very Severe Alopecia Areata

This study is designed to select up to two doses of baricitinib (referred to as low dose and high dose) and assess their efficacy and safety for the treatment of severe or very severe alopecia areata.

Phase

PF-06651600 for the Treatment of Alopecia Areata

This is a global Phase 2b/3 study to evaluate the safety and effectiveness of an investigational study drug (called PF-06651600) in adults and adolescents (12 years and older) who have 50% or greater scalp hair loss. The study is placebo-controlled, meaning that some patients entering the study will not receive ...

Phase